Also, in models of type 1 diabetes, blocking the TRAIL activity accelerated the development of hyperglycemia [14], whereas systemic overexpression of TRAIL significantly reduced the blood glucose concentration [15]. The gene discussed is TNFSF10; the disease is type 1 diabetes mellitus.